Newsletter registration

Австрия
динамичная площадка для ведения бизнеса

Large-Scale Investment of Baxter/Baxalta in Austria

The American pharmaceutical and biotechology giant Baxter is investing EUR 138 million in Krems, Austria under its new name of Baxalta. The production facility in Krems will be expanded and modernized, creating 100 new jobs.   

The American pharmaceutical group Baxter is divided as of now into new separate publicly listed companies, one for its medical products and the other for its bioscience operations. The biotech division will be called Baxalta effective immediately. The Austrian plants in Krems and Orth/Donau both fully belong to the new biotech company Baxalta.  

The project which was announced calls for a blood clotting drug to be produced in Krems starting in 2018. “Over the past years we have had good experience with our production plant in Krems. Not only do we find very well trained employees here, but above all the possibility to partner with IMC University of Applied Sciences Krems and other specific facilities provides many advantages. For this reason, last year we reached an agreement to cooperate with IMC on research projects”, says Michael Heinrich of Baxalta, justifying the decision.  

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Отзывы

Мероприятия

Познакомьтесь с нами в рамках мероприятий, семинаров и выставок по всему миру

Austria Map

Find the perfect location for your company

Австрия занимает ключевую позицию для бизнеса между Востоком и Западом. Мы высоко ценим превосходную инфраструктуру, в особенной мере отличное воздушное сообщение, высококвалифицированные трудовые кадры, а также первоклассное качество жизни в Вене.

ЛУКОЙЛ

Lukoil Logo
Все отзывы

Новости Австрии, как площадки для бизнеса

Jaguar E-Pace rolls off the assembly lines in Austria

The new Jaguar SUV named E-Pace is being manufactured by Magna in Graz, the second vehicle of the British producer to be assembled in Austria.

Testing the potential early detection of ovarian cancer

About 75 percent of the cases of extremely aggressive ovarian cancer (ovarian carcinoma) originally arise in the fallopian tube. Currently there are no possibilities to detect this at an early stage. A new catheter system developed by Viennese scientists could represent a new possibility to deal with this.

Все новости